Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale
- PMID: 15694876
- DOI: 10.1016/j.jpain.2004.11.002
Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale
Erratum in
- J Pain. 2005 Sep;6(9):637
Abstract
Although a number of measures of pain qualities exist, little research has examined the potential for these measures to identify the unique effects of pain treatments on different pain qualities. We examined the utility of the Neuropathic Pain Scale (NPS) for assessing changes in pain qualities after open label lidocaine patch 5% in 3 samples of patients: patients with peripheral neuropathic pain, low back pain, and osteoarthritis. With one exception ("cold" pain in subjects with low back pain), each of the NPS items showed significant change after open label lidocaine patch. In addition, significantly larger changes were observed for the NPS items reflecting global pain intensity and pain unpleasantness and for items assessing sharp and deep pain than for items assessing cold, sensitive, and itchy pain. The pattern of changes in pain qualities did not differ across the 3 diagnostic groups, but it did differ from the patterns of changes in pain qualities associated with other analgesic treatments. The results support the potential utility of the NPS for assessing the patterns of changes in pain qualities that can be observed after pain treatment.
Perspective: Pain clinical trials that include measures of pain qualities, such as the NPS, might identify distinct patterns of treatment effects on those pain qualities. This research might be used to help clinicians target analgesics to match the specific qualities associated with a patient's pain and to better understand the mechanisms of analgesic effects in drug development programs.
Similar articles
-
Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale.Curr Med Res Opin. 2004;20 Suppl 2:S13-9. doi: 10.1185/030079904X12951. Curr Med Res Opin. 2004. PMID: 15563742 Clinical Trial.
-
Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.Curr Med Res Opin. 2004;20 Suppl 2:S21-8. doi: 10.1185/030079904X12960. Curr Med Res Opin. 2004. PMID: 15563743 Clinical Trial.
-
Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale.Curr Med Res Opin. 2004;20 Suppl 2:S29-31. doi: 10.1185/030079904X12979. Curr Med Res Opin. 2004. PMID: 15563744
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
[Localized neuropathic pain--5% lidocaine medicated patch as a first-line treatment and as add-on therapy: literature review and personal experience].Minerva Med. 2014 Jun;105(3):177-95. Minerva Med. 2014. PMID: 24988084 Review. Italian.
Cited by
-
Pain quality descriptors and sex-related differences in patients with shoulder pain.J Pain Res. 2018 Sep 11;11:1803-1809. doi: 10.2147/JPR.S169006. eCollection 2018. J Pain Res. 2018. PMID: 30254482 Free PMC article.
-
Chemotherapy-Induced Neuropathy in Cancer Survivors.J Pain Symptom Manage. 2017 Aug;54(2):204-218.e2. doi: 10.1016/j.jpainsymman.2016.12.342. Epub 2017 Jan 4. J Pain Symptom Manage. 2017. PMID: 28063866 Free PMC article.
-
Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.Eur J Oncol Nurs. 2018 Feb;32:1-11. doi: 10.1016/j.ejon.2017.10.006. Epub 2017 Nov 7. Eur J Oncol Nurs. 2018. PMID: 29353626 Free PMC article.
-
Risk Factors of Neuropathic Pain after Total Hip Arthroplasty.Hip Pelvis. 2018 Dec;30(4):226-232. doi: 10.5371/hp.2018.30.4.226. Epub 2018 Dec 6. Hip Pelvis. 2018. PMID: 30534541 Free PMC article.
-
Soreness or sng: a common symptom with differential clinical impact from pain in degenerative lumbar spine diseases.BMJ Open Qual. 2023 Jan;12(1):e001982. doi: 10.1136/bmjoq-2022-001982. BMJ Open Qual. 2023. PMID: 36690383 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources